Side-by-Side Comparison

Retatrutide vs Tirzepatide

Dosing, half-life, mechanism, benefits, and safety — side by side.

Retatrutide

Research

Triple GLP-1/GIP/glucagon agonist showing exceptional weight loss potential

Half-Life

4-5 days

Route

Dose

4-12mg weekly

4889.48 Da

Full Retatrutide research guide →

Tirzepatide

FDA Approved

Dual GLP-1/GIP receptor agonist with superior weight loss efficacy

Half-Life

~5 days

Route

Dose

2.5-15 mg Weekly

4813.45 Da

Full Tirzepatide research guide →

Quick Reference

	Retatrutide	Tirzepatide
Category	N/A	N/A
Route	SC	SC
Typical Dose	4-12mg weekly	2.5-15 mg Weekly
Frequency	weekly	Weekly
FDA Approved	No	Yes
WADA Status	Not banned	Not banned

⏱ Pharmacokinetics

	Retatrutide	Tirzepatide
Half-Life	4-5 days	~5 days
Research Status	Phase 3 Clinical Trials - Triple agonist	N/A
CAS Number	2381089-83-2	2023788-19-2

Molecular

	Retatrutide	Tirzepatide
Molecular Weight	4889.48	4813.45
Molecular Formula	C69H42N6O	C225H348N48O68
Sequence Length	180 aa	180 aa
Mechanism	Triple agonist (GLP-1/GIP/Glucagon) for superior metabolic health and weight loss	Dual GLP-1/GIP receptor agonist for enhanced metabolic effects

Key Benefits

	Retatrutide	Tirzepatide
Benefits	Triple hormone pathway activation; Metabolic optimization; Enhanced fat burning; Improved insulin sensitivity; Exceptional weight loss potential; Triple agonist (GLP-1; GIP; Glucagon)	Superior weight loss vs GLP-1 alone; Enhanced glycemic control; Dual hormone pathway activation; Cardiovascular protection; Improved metabolic parameters; Dual agonist (GLP-1; GIP); Superior weight loss vs Semaglutide

Safety & Warnings

	Retatrutide	Tirzepatide
Safety Note	Investigational compound in Phase 3 trials. Not yet approved for clinical use.	FDA approved. Most common side effects are GI-related and typically mild to moderate.
Side Effects	Nausea; Vomiting; Diarrhea; Interaction; Interaction; Constipation; Rare pancreatitis/gallstones; Mild-Moderate side effect	Interaction; Interaction; GI events; Discontinuation; Nausea; Vomiting; Rare pancreatitis/gallbladder disease; Constipation
Athlete Warning	Not WADA banned - investigational metabolic compound safe for competitive athletes under medical supervision	Not WADA banned - safe for competitive athletes when used under medical supervision

Which should you choose?

Tirzepatide has FDA-approved status while Retatrutide remains a research compound — relevant if regulatory standing matters to you. Retatrutide has a longer half-life (~4-5 days) than Tirzepatide (~~5 days), which can mean less frequent dosing.

Retatrutide vs Tirzepatide — FAQ

Which has a longer half-life: Retatrutide or Tirzepatide?

Retatrutide has a half-life of ~4-5 days while Tirzepatide has a half-life of ~~5 days. A longer half-life generally means less frequent dosing and more stable levels.

Is Retatrutide or Tirzepatide FDA approved?

Tirzepatide is FDA approved, while Retatrutide is a research compound without FDA approval. Always research regulatory status in your jurisdiction.

Can I stack Retatrutide and Tirzepatide together?

Whether Retatrutide and Tirzepatide can be stacked depends on their mechanisms and receptor targets. Use the stack compatibility checker to analyze synergies and conflicts before combining any peptides.

Which is better: Retatrutide or Tirzepatide?

There is no universal "better" peptide — it depends on your goal. Retatrutide is Triple agonist (GLP-1/GIP/Glucagon) for superior metabolic health and weight loss. Tirzepatide is Dual GLP-1/GIP receptor agonist for enhanced metabolic effects. Choose based on your primary goal and research profile.

Compare any two peptides Check stack compatibility

More Comparisons

Tirzepatide vs Semaglutide

Compare side-by-side →

BPC-157 vs TB-500

Compare side-by-side →

Semaglutide vs Retatrutide

Compare side-by-side →

Ipamorelin vs Sermorelin

Compare side-by-side →

CJC-1295 vs Sermorelin

Compare side-by-side →

MK-677 vs Ipamorelin

Compare side-by-side →

GHK-Cu vs AHK-Cu

Compare side-by-side →

Selank vs Semax

Compare side-by-side →

MOTS-c vs NAD+

Compare side-by-side →

PT-141 vs Melanotan-II

Compare side-by-side →

Tesamorelin vs CJC-1295

Compare side-by-side →

HGH vs MK-677

Compare side-by-side →

Semaglutide vs Liraglutide

Compare side-by-side →